One More Step!

Opening Recap Market Pulse: U.S. equities edged higher after choppy mid-week trading, buoyed by renewed confidence in AI deployments across chipmakers and software pure-plays. Key

Company Overview & Leadership Changes Alterity Therapeutics (ASX: ATH; NASDAQ: ATHE) is a clinical-stage biotech focused on neurodegenerative diseases, with its lead drug candidate ATH434

Market Pulse: Equity traders swung toward growth after Sequoia locked in a $7 billion war chest for AI bets. Robotics news out of Taiwan and